查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590925

醫療保健受託研究機構市場：按類型、服務分類 - 2025-2030 年全球預測

Healthcare Contract Research Organization Market by Type (Clinical, Drug Discovery, Pre-Clinical), Service (Bio-Statistics, Clinical Monitoring, Data Management) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，醫療保健受託研究機構市場價值為568.6億美元，預計到2024年將達到635.2億美元，複合年成長率為11.82%，到2030年將達到1243億美元。

醫療保健受託研究機構(CRO) 市場包括為製藥、生物技術和醫療設備產業提供的廣泛服務，包括藥物發現、臨床試驗、資料管理、監管合規和上市後監測。由於臨床開發的複雜性、成本和持續時間，CRO 至關重要，它使公司能夠加快上市時間並最佳化資源，同時降低財務風險。應用範圍從臨床前研究到 IV 期試驗，最終用途包括製藥、生技公司和醫療設備製造商。關鍵的成長要素包括對創新療法的需求不斷成長推動的臨床試驗數量的增加、加快藥物核准的監管壓力以及研發支出的增加。在巨量資料、人工智慧和機器學習進步的推動下，醫療保健的數位轉型正在為臨床試驗效率、病患招募和資料分析等創造新的機會。在臨床研究活動活性化和有利的法規環境的推動下，亞太和拉丁美洲等新興市場顯示出巨大潛力。然而，他們面臨嚴格的監管要求、複雜的合約管理和高昂的營運成本等挑戰。智慧財產權問題和熟練專業人員的短缺使市場動態更加複雜。為了利用成長機會，CRO 應優先考慮整合尖端數位解決方案，建立策略夥伴關係關係，並專注於罕見疾病和個人化醫療等利基研究領域。創新的目標是透過自動化簡化流程並促進以患者為中心的試驗設計。儘管市場成長潛力巨大，但市場競爭仍然激烈，需要策略差異化和嚴格的品質合規性。為了實現永續的業務成長，在遵守各國監管情況的同時投資全球擴張非常重要。因此，CRO 市場是一個充滿挑戰和機會的動態組合，需要敏捷性和創新來引領市場。

主要市場統計
基準年[2023] 568.6億美元
預測年份 [2024] 635.2億美元
預測年份 [2030] 1,243億美元
複合年成長率（%） 11.82%

市場動態：針對快速發展的醫療保健受託研究機構市場揭示的關鍵市場洞察

醫療保健受託研究機構市場正在因供需的動態相互作用而發生轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 製藥公司外包端到端服務的趨勢不斷成長
    • 擴大再生醫學投資
    • 對專業測試服務的需求不斷成長
  • 市場限制因素
    • 熟練專業人員減少
  • 市場機會
    • 生物相似藥和生技藥品領域的需求不斷增加
    • 醫療受託研究機構引進新技術
  • 市場挑戰
    • 醫療保健CRO服務的品質問題

波特的五力：駕馭醫療保健受託研究機構市場的策略工具

波特的「五力」框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療保健受託研究機構市場的外部影響

外部宏觀環境因素在塑造醫療受託研究機構市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解醫療保健受託研究機構市場的競爭狀況

對醫療保健受託研究機構市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 醫療保健受託研究機構市場中的定位矩陣供應商績效評估

FPNV 定位矩陣是評估醫療保健受託研究機構市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃醫療保健受託研究機構市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對醫療保健受託研究機構市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司端到端外包趨勢增加
      • 加大再生醫學投資
      • 對專業測試服務的需求增加
    • 抑制因素
      • 熟練專業人員減少
    • 機會
      • 生物相似藥和生技藥品產業的新需求
      • 醫療保健合約研究機構引進新技術
    • 任務
      • 醫療保健CRO服務的品質問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 醫療保健受託研究機構市場：按類型

  • 臨床
    • 一期測試服務
    • 二期測試服務
    • 三期測試服務
    • IV期測試服務
  • 藥物發現
    • 線索識別
    • 先導藥物最適化
    • 目標檢驗
  • 臨床前

第7章 醫療保健受託研究機構市場：依服務分類

  • 生物統計學
  • 臨床監測
  • 資料管理
  • 支付給調查員
  • 實驗室
  • 醫學寫作
  • 病人和設施招募
  • 計劃管理/臨床供應管理
  • 品管/保證
  • 監管/醫療
  • 科技

第8章美洲醫療保健受託研究機構市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太醫療保健受託研究機構市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的醫療保健受託研究機構市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advanced Clinical
  • Charles River Laboratories, Inc.
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Inc.
  • KCR SA
  • Labcorp Drug Development
  • Medpace, Inc.
  • Parexel International Corporation
  • Pharmaron
  • PPD LLC by Thermo Fisher Scientific Inc.
  • SGS Societe Generale de Surveillance SA
  • Syneos Health
  • Syngene International Limited
  • WuXi AppTec
Product Code: MRR-A339DAEFAF80

The Healthcare Contract Research Organization Market was valued at USD 56.86 billion in 2023, expected to reach USD 63.52 billion in 2024, and is projected to grow at a CAGR of 11.82%, to USD 124.30 billion by 2030.

The healthcare contract research organization (CRO) market encompasses a broad range of services provided to pharmaceutical, biotechnology, and medical device sectors, including drug discovery, clinical trials, data management, regulatory compliance, and post-market surveillance. CROs are indispensable due to the complexity, cost, and duration of clinical development, enabling companies to accelerate time-to-market and optimize resources with reduced financial risk. The application scope spans from preclinical studies to Phase IV trials, while end-use extends to pharmaceuticals, biotechnology firms, and medical device manufacturers. Key growth factors include the rising number of clinical trials driven by increasing demand for innovative therapeutics, regulatory pressure demanding faster drug approvals, and expanding R&D expenditure. The digital transformation of healthcare, fostering advancements in big data, artificial intelligence, and machine learning, presents new opportunities, particularly in enhancing trial efficiency, patient recruitment, and data analytics. Emerging markets, like Asia-Pacific and Latin America, exhibit significant potential, driven by increased clinical research activities and favorable regulatory environments. However, the market faces challenges such as stringent regulatory requirements, complex contract management, and high operational costs. Intellectual property concerns and a shortage of skilled professionals further complicate market dynamics. To capitalize on growth opportunities, CROs should prioritize integration of cutting-edge digital solutions, forge strategic partnerships, and focus on niche research areas such as rare diseases and personalized medicine. Innovation should target streamlining processes through automation and fostering patient-centric trial designs. Despite its growth potential, the market's nature remains competitive, necessitating strategic differentiation and robust quality compliance. Investing in global expansion while ensuring adherence to local regulatory landscapes will be crucial for sustained business growth. Consequently, the CRO market presents a dynamic blend of challenges and opportunities, necessitating agility and innovation for market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 56.86 billion
Estimated Year [2024] USD 63.52 billion
Forecast Year [2030] USD 124.30 billion
CAGR (%) 11.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Research Organization Market

The Healthcare Contract Research Organization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • Growing investments in regenerative medicine
    • Increasing need among specialized testing services
  • Market Restraints
    • Reduced skilled professionals
  • Market Opportunities
    • Emerging demand from biosimilars and biologics sector
    • Incorporation of novel technologies by healthcare contract research organizations
  • Market Challenges
    • Quality issues of healthcare CRO services

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Research Organization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Research Organization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Research Organization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Research Organization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Research Organization Market

A detailed market share analysis in the Healthcare Contract Research Organization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Research Organization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Research Organization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Research Organization Market

A strategic analysis of the Healthcare Contract Research Organization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Research Organization Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical, Charles River Laboratories, Inc., Eurofins Scientific SE, ICON plc, IQVIA Inc., KCR S.A., Labcorp Drug Development, Medpace, Inc., Parexel International Corporation, Pharmaron, PPD LLC by Thermo Fisher Scientific Inc., SGS Societe Generale de Surveillance SA, Syneos Health, Syngene International Limited, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Research Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead Identification, Lead Optimization, and Target Validation.
  • Based on Service, market is studied across Bio-Statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient & Site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Growing investments in regenerative medicine
      • 5.1.1.3. Increasing need among specialized testing services
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand from biosimilars and biologics sector
      • 5.1.3.2. Incorporation of novel technologies by healthcare contract research organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Quality issues of healthcare CRO services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Research Organization Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Phase I Trial Services
    • 6.2.2. Phase II Trial Services
    • 6.2.3. Phase III Trial Services
    • 6.2.4. Phase IV Trial Services
  • 6.3. Drug Discovery
    • 6.3.1. Lead Identification
    • 6.3.2. Lead Optimization
    • 6.3.3. Target Validation
  • 6.4. Pre-Clinical

7. Healthcare Contract Research Organization Market, by Service

  • 7.1. Introduction
  • 7.2. Bio-Statistics
  • 7.3. Clinical Monitoring
  • 7.4. Data Management
  • 7.5. Investigator Payments
  • 7.6. Laboratory
  • 7.7. Medical Writing
  • 7.8. Patient & Site Recruitment
  • 7.9. Project Management/Clinical Supply Management
  • 7.10. Quality Management/ Assurance
  • 7.11. Regulatory/Medical Affairs
  • 7.12. Technology

8. Americas Healthcare Contract Research Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Research Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Research Organization Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Clinical
  • 2. Charles River Laboratories, Inc.
  • 3. Eurofins Scientific SE
  • 4. ICON plc
  • 5. IQVIA Inc.
  • 6. KCR S.A.
  • 7. Labcorp Drug Development
  • 8. Medpace, Inc.
  • 9. Parexel International Corporation
  • 10. Pharmaron
  • 11. PPD LLC by Thermo Fisher Scientific Inc.
  • 12. SGS Societe Generale de Surveillance SA
  • 13. Syneos Health
  • 14. Syngene International Limited
  • 15. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT & SITE RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 200. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 201. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023